Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Joly, F, Baxter, J, Staun, M, Kelly, DG, Hwa, YL, Corcos, O, De Francesco, A, Agostini, F, Klek, S, Santarpia, L, Contaldo, F, Jonker, C, Wanten, G, Chicharro, L, Burgos, R, Van Gossum, A, Cuerda, C, Virgili, N, Pironi, L & ESPEN HAN CIF group 2018, 'Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure' Clinical nutrition (Edinburgh, Scotland), vol. 37, no. 4, pp. 1415-1422. https://doi.org/10.1016/j.clnu.2017.06.016

APA

CBE

Joly F, Baxter J, Staun M, Kelly DG, Hwa YL, Corcos O, De Francesco A, Agostini F, Klek S, Santarpia L, Contaldo F, Jonker C, Wanten G, Chicharro L, Burgos R, Van Gossum A, Cuerda C, Virgili N, Pironi L, ESPEN HAN CIF group. 2018. Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure. Clinical nutrition (Edinburgh, Scotland). 37(4):1415-1422. https://doi.org/10.1016/j.clnu.2017.06.016

MLA

Vancouver

Author

Joly, Francisca ; Baxter, Janet ; Staun, Michael ; Kelly, Darlene G ; Hwa, Yi Lisa ; Corcos, Olivier ; De Francesco, Antonella ; Agostini, Federica ; Klek, Stanislaw ; Santarpia, Lidia ; Contaldo, Franco ; Jonker, Cora ; Wanten, Geert ; Chicharro, Luisa ; Burgos, Rosa ; Van Gossum, Andre ; Cuerda, Cristina ; Virgili, Nuria ; Pironi, Loris ; ESPEN HAN CIF group. / Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure. In: Clinical nutrition (Edinburgh, Scotland). 2018 ; Vol. 37, No. 4. pp. 1415-1422.

Bibtex

@article{46d1dbd9e1a549afa1c44c8fef1bebcd,
title = "Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure",
abstract = "BACKGROUND & AIM: Home parenteral nutrition (HPN) is the primary treatment for chronic intestinal failure (IF). Intestinal transplantation (ITx) is indicated when there is an increased risk of death due to HPN complications or to the underlying disease. Age, pathophysiologic conditions and underlying disease are known predictors of HPN dependency and overall survival. Although the cause of death on HPN is mostly related to underlying disease in these patients, the relationship between mortality and duration of HPN use remains unclear. The purpose of the present study is to describe factors associated with survival and HPN dependency as well as causes of death in adult patients requiring HPN for chronic intestinal failure during the first 5 years of treatment with HPN.METHODS: A multicenter international (European and USA) questionnaire-based retrospective follow-up of a cohort of 472 IF patients who started HPN was conducted between June and December 2000. Study endpoint was either end of 5-year follow-up, weaned-off HPN, ITx, or death on HPN. Data were analyzed for HPN dependence and overall survival using Kaplan-Meier models and log rank tests.RESULTS: The overall survival probability was 88{\%}, 74{\%} and 64{\%} at 1, 3 and 5 years respectively. Survival was inversely related to age (p < .001) and higher in patients with Crohn's disease or chronic idiopathic pseudo-obstruction. A total of 169 (36.5{\%}) patients were weaned-off HPN mainly (80{\%}) within the first year and most frequently in patients with fistulae. Five of the 14 patients who underwent ITx died. By the end of the study, 104 (23{\%}) of patients died on HPN; 65{\%} of deaths occurred within the first 2.5 years of HPN.CONCLUSIONS: Younger ages at HPN initiation and underlying pathologies are significantly predictive of survival on HPN. Risk of death is greatest during the first 2 years of HPN.",
keywords = "Journal Article",
author = "Francisca Joly and Janet Baxter and Michael Staun and Kelly, {Darlene G} and Hwa, {Yi Lisa} and Olivier Corcos and {De Francesco}, Antonella and Federica Agostini and Stanislaw Klek and Lidia Santarpia and Franco Contaldo and Cora Jonker and Geert Wanten and Luisa Chicharro and Rosa Burgos and {Van Gossum}, Andre and Cristina Cuerda and Nuria Virgili and Loris Pironi and {ESPEN HAN CIF group}",
note = "Copyright {\circledC} 2017 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.",
year = "2018",
doi = "10.1016/j.clnu.2017.06.016",
language = "English",
volume = "37",
pages = "1415--1422",
journal = "Clinical Nutrition, Supplement",
issn = "0261-5614",
publisher = "Elsevier BV",
number = "4",

}

RIS

TY - JOUR

T1 - Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure

AU - Joly, Francisca

AU - Baxter, Janet

AU - Staun, Michael

AU - Kelly, Darlene G

AU - Hwa, Yi Lisa

AU - Corcos, Olivier

AU - De Francesco, Antonella

AU - Agostini, Federica

AU - Klek, Stanislaw

AU - Santarpia, Lidia

AU - Contaldo, Franco

AU - Jonker, Cora

AU - Wanten, Geert

AU - Chicharro, Luisa

AU - Burgos, Rosa

AU - Van Gossum, Andre

AU - Cuerda, Cristina

AU - Virgili, Nuria

AU - Pironi, Loris

AU - ESPEN HAN CIF group

N1 - Copyright © 2017 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

PY - 2018

Y1 - 2018

N2 - BACKGROUND & AIM: Home parenteral nutrition (HPN) is the primary treatment for chronic intestinal failure (IF). Intestinal transplantation (ITx) is indicated when there is an increased risk of death due to HPN complications or to the underlying disease. Age, pathophysiologic conditions and underlying disease are known predictors of HPN dependency and overall survival. Although the cause of death on HPN is mostly related to underlying disease in these patients, the relationship between mortality and duration of HPN use remains unclear. The purpose of the present study is to describe factors associated with survival and HPN dependency as well as causes of death in adult patients requiring HPN for chronic intestinal failure during the first 5 years of treatment with HPN.METHODS: A multicenter international (European and USA) questionnaire-based retrospective follow-up of a cohort of 472 IF patients who started HPN was conducted between June and December 2000. Study endpoint was either end of 5-year follow-up, weaned-off HPN, ITx, or death on HPN. Data were analyzed for HPN dependence and overall survival using Kaplan-Meier models and log rank tests.RESULTS: The overall survival probability was 88%, 74% and 64% at 1, 3 and 5 years respectively. Survival was inversely related to age (p < .001) and higher in patients with Crohn's disease or chronic idiopathic pseudo-obstruction. A total of 169 (36.5%) patients were weaned-off HPN mainly (80%) within the first year and most frequently in patients with fistulae. Five of the 14 patients who underwent ITx died. By the end of the study, 104 (23%) of patients died on HPN; 65% of deaths occurred within the first 2.5 years of HPN.CONCLUSIONS: Younger ages at HPN initiation and underlying pathologies are significantly predictive of survival on HPN. Risk of death is greatest during the first 2 years of HPN.

AB - BACKGROUND & AIM: Home parenteral nutrition (HPN) is the primary treatment for chronic intestinal failure (IF). Intestinal transplantation (ITx) is indicated when there is an increased risk of death due to HPN complications or to the underlying disease. Age, pathophysiologic conditions and underlying disease are known predictors of HPN dependency and overall survival. Although the cause of death on HPN is mostly related to underlying disease in these patients, the relationship between mortality and duration of HPN use remains unclear. The purpose of the present study is to describe factors associated with survival and HPN dependency as well as causes of death in adult patients requiring HPN for chronic intestinal failure during the first 5 years of treatment with HPN.METHODS: A multicenter international (European and USA) questionnaire-based retrospective follow-up of a cohort of 472 IF patients who started HPN was conducted between June and December 2000. Study endpoint was either end of 5-year follow-up, weaned-off HPN, ITx, or death on HPN. Data were analyzed for HPN dependence and overall survival using Kaplan-Meier models and log rank tests.RESULTS: The overall survival probability was 88%, 74% and 64% at 1, 3 and 5 years respectively. Survival was inversely related to age (p < .001) and higher in patients with Crohn's disease or chronic idiopathic pseudo-obstruction. A total of 169 (36.5%) patients were weaned-off HPN mainly (80%) within the first year and most frequently in patients with fistulae. Five of the 14 patients who underwent ITx died. By the end of the study, 104 (23%) of patients died on HPN; 65% of deaths occurred within the first 2.5 years of HPN.CONCLUSIONS: Younger ages at HPN initiation and underlying pathologies are significantly predictive of survival on HPN. Risk of death is greatest during the first 2 years of HPN.

KW - Journal Article

U2 - 10.1016/j.clnu.2017.06.016

DO - 10.1016/j.clnu.2017.06.016

M3 - Journal article

VL - 37

SP - 1415

EP - 1422

JO - Clinical Nutrition, Supplement

JF - Clinical Nutrition, Supplement

SN - 0261-5614

IS - 4

ER -

ID: 52744491